Join Now

Author Archives: Denise Bell

BioUtah Recognizes Rare Disease Day

By Denise Bell | Published March 1, 2021

Today, BioUtah recognizes Rare Disease Day – its patients, families, healthcare providers, advocates, policymakers and drug manufacturers – all dedicated to making a difference in the fight against rare disease. Here in Utah, we are working closely with our partners in the rare disease community to raise awareness and harness resources to support the goal […]

Posted in Policy News | Leave a comment

2021 BioHive Entrepreneur and Investor Life Sciences Summit BioHive, J.P. Morgan, Pitch Competition, Local, National Investors and More…

By Denise Bell | Published March 1, 2021

ICYMI If you missed the 2021 BioHive Entrepreneur and Investor Life Sciences (E&I) Summit or weren’t able to attend all the sessions, you can access the programming for a limited time. Registered attendees can access recorded sessions free of charge. Not already registered? You can register and access the program for $25. The 2021 E&I […]

Posted in BioUtah News, Events, Life Sciences Events | Leave a comment

BioUtah Hosts LIfe Sciences Roundtable with Congressional Healthcare Leaders

By Denise Bell | Published March 1, 2021

BioUtah recently held a life sciences industry roundtable with Republican lawmakers in the U.S. House of Representatives who play a key role in shaping healthcare policy around the FDA, CMS, NIH and more. Lawmakers included our own Rep. John Curtis (R-UT) who now sits on the House Energy and Commerce (E&C) Committee and Subcommittee on […]

Posted in BioUtah News, Policy News | Leave a comment

American Society of Nephrology and Renalytix Co-Host Virtual Capital Markets Day for Kidney Health

By Denise Bell | Published February 12, 2021

RenalytixAI co-hosted a Capital Markets Day for Kidney Health with the American Society of Nephrology yesterday, Feb. 11. The virtual event brought together a broad group of delegates representing the kidney community, including leading clinicians, representatives of U.S. government health agencies, kidney care innovators and investors focused on life sciences and medical technology, for a […]

Posted in BioUtah News, Industry News, Utah's Life Sciences Companies | Leave a comment

Attostat is now EVŌQ Nano – Seeks Next Round of Investment Following Antimicrobial Efficacy Studies

By Denise Bell | Published February 12, 2021

Attostat is now EVŌQ Nano! The Utah start-up has a new name, a clean look and a fresh website. Following years of scientific research and development, EVŌQ Nano is ready to share its story of next-generation nanotechnology and raise its next round of investment. “We truly are a thought leader in nanotechnology,” said CEO Scott […]

Posted in BioUtah News, Industry News, Utah's Life Sciences Companies | Leave a comment

Novel Embolic Device Used for Arterial and Venous Tumor Treatments

By Denise Bell | Published February 5, 2021

Fluidx Medical Technology has announced successful patient use of the GPX Embolic Device to therapeutically devascularize, or block blood supply to, a tumor. The GPX Embolic Device is an innovative embolic designed to combine the benefits of other embolics like coils, particles, and liquids with simplified preparation, delivery, precision, and control leading to durable, long-term […]

Posted in BioUtah News, Industry News, Life Sciences Industry News, Utah's Life Sciences Companies | Leave a comment

MAYOR ERIN MENDENHALL’S SALT LAKE CITY 2021 PLAN INCLUDES BIOHIVE

By Denise Bell | Published January 29, 2021

Last week, Salt Lake City (SLC) Mayor Erin Mendenhall gave her second State of the City address – a live broadcast from the City Council Chambers in which she reflected on 2020 and outlined her plan for the City in 2021. The Mayor noted that “we are striving to make our city better through change; […]

Posted in BioUtah News, Economic Developments, State News, Utah's Life Sciences Companies | Leave a comment

Spectrum Solutions Collaborates with UCLA on Saliva-Based Next-Gen Sequencing (NGS) Liquid Biopsy Research for the Early Detection of Lung Cancer

By Denise Bell | Published January 29, 2021

Spectrum Solutions, LLC on January 27 announced it is sponsoring research in collaboration with the UCLA School of Dentistry for a study on using saliva in early lung cancer detection and analysis. Spectrum has funded a study that aims to recruit 50 patients with lung cancer and seeks to validate saliva’s tumor-specific ctDNA detection sensitivity […]

Posted in BioUtah News, State News, Utah's Life Sciences Companies | Leave a comment

Control Medical Technology Announces New Device Removes Large Blood Clots in 1st Deep Vein Thrombosis (DVT) Patient Use

By Denise Bell | Published January 22, 2021

Control Medical Technology today announced the FDA cleared Control 11F Mechanical Thrombectomy system was used to remove large blood clots from patients with deep vein thrombosis (DVT). The system is Utah born, designed, engineered, patent prosecuted, and manufactured. “The Control 11 French Mechanical Thrombectomy System can remove large clots,” said Shawn Fojtik, President of Control […]

Posted in Industry News, Policy News, Utah's Life Sciences Companies | Leave a comment

President Biden Unveils COVID-19 Vaccine Plan

By Denise Bell | Published January 22, 2021

In an effort to speed up vaccinations after a slower than expected rollout, HHS last week began encouraging states to start vaccinating individuals 65 and older, along with those ages 16 and older with comorbidities. Meanwhile President Biden unveiled a COVID-19 vaccination plan which aims to pick up the pace of vaccinations by creating federal […]

Posted in Policy News | Leave a comment

President Biden Unveils COVID-19 Relief Plan

By Denise Bell | Published January 22, 2021

President Biden has unveiled the first part in his two-part plan for rescue and economic recovery—the American Rescue Plan. He is expected to lay out part two – the Build Back Better Recovery Plan, next month. The $1.9 trillion American Rescue Plan is intended to address immediate COVID-19 needs, while the Build Back Better Recovery […]

Posted in Policy News | Leave a comment

Day One – Biden Administration Issues Regulatory Freeze

By Denise Bell | Published January 22, 2021

Issuing a regulatory freeze is standard practice for an incoming administration, so as expected, shortly after President Biden was sworn in on January 20, the White House issued a memo directing agencies to freeze for 60 days any agency rules or guidance issued by the Trump administration that have not taken effect by Inauguration Day. […]

Posted in Policy News | Leave a comment

A Special Thanks To Our Elite Members